Baxter International (BAX) vs Globus Medical (GMED)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Globus Medical (GMED) has outperformed Baxter International (BAX) over the past year, gaining 21.4% versus a gain of 5.1%. Over five years, GMED leads with a -4.1% price change compared with -70.0% for BAX. Baxter International is the larger company by market cap ($12.43 billion vs $10.02 billion), about 1.2 times the size, while Globus Medical is growing revenue faster (+16.7% vs +5.7%).
On valuation, Baxter International trades at a lower forward P/E (11.8x vs 13.8x for Globus Medical). Baxter International pays a dividend yielding 0.83%, while Globus Medical does not currently pay one. Globus Medical converts more of its revenue into profit, with a net margin of 18.3% versus -8.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BAX | GMED |
|---|---|---|
| Share price | $24.05 | $74.62 |
| Market cap | $12.43B | $10.02B |
| 1-day change | +0.63% | +1.76% |
| YTD return | +25.07% | -16.01% |
| 1-year return | +5.05% | +21.37% |
| 5-year return | -70.01% | -4.06% |
| P/E ratio (TTM) | — | 19.13 |
| Forward P/E | 11.79 | 13.82 |
| EPS (TTM) | $-1.88 | $3.90 |
| Dividend yield | 0.83% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $11.24B | $2.94B |
| Revenue growth (YoY) | +5.72% | +16.65% |
| Net income (latest FY) | $-957.00M | $537.87M |
| Gross margin | 30.05% | 67.41% |
| Operating margin | -2.74% | 16.33% |
| Net margin | -8.51% | 18.30% |
| 52-week high | $30.00 | $101.40 |
| 52-week low | $15.73 | $56.50 |
| Distance from 52-week high | -19.83% | -26.41% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +16.09% | +35.25% |
| Average volume | 6.66M | 1.51M |
| Shares outstanding | 517.00M | 111.83M |
| Employees | 37,500 | 6,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GMED has outperformed BAX by 16.3 percentage points over the past year.
- Globus Medical is more profitable, keeping 18.3 cents of every revenue dollar as net income versus -8.5 cents for Baxter International.
- Globus Medical grew revenue faster in its latest fiscal year (+16.65% vs +5.72%).
About Baxter International
BAX stock →Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Health Care · Medical/Dental Instruments · 37,500 employees
About Globus Medical
GMED stock →Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 6,000 employees
BAX vs GMED FAQ
Which is bigger, Baxter International or Globus Medical?
Baxter International (BAX) is larger, with a market capitalization of $12.43B compared with $10.02B for Globus Medical (GMED).
Which stock has performed better over the past year, BAX or GMED?
GMED returned +21.37% over the past 12 months, compared with +5.05% for BAX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Baxter International or Globus Medical?
Baxter International pays a dividend yielding 0.83%, while Globus Medical does not currently pay a regular dividend.
Are Baxter International and Globus Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.